Literature DB >> 15920019

Neuropilin-1 regulates vascular endothelial growth factor-mediated endothelial permeability.

Patrice M Becker1, Johannes Waltenberger, Robin Yachechko, Tamara Mirzapoiazova, James S K Sham, Chun Geun Lee, Jack A Elias, Alexander D Verin.   

Abstract

Neuropilin-1 (Npn-1) is a cell surface receptor that binds vascular endothelial growth factor (VEGF), a potent mediator of endothelial permeability, chemotaxis, and proliferation. In vitro, Npn-1 can complex with VEGF receptor-2 (VEGFR2) to enhance VEGFR2-mediated endothelial cell chemotaxis and proliferation. To determine the role of Npn-1/VEGFR2 complexes in VEGF-induced endothelial barrier dysfunction, endothelial cells were stably transfected with Npn1 or VEGFR2 alone (PAE/Npn and PAE/KDR, respectively), or VEGFR2 and Npn-1 (PAE/KDR/Npn-1). Permeability, estimated by measurement of transendothelial electrical resistance (TER), of PAE/Npn and PAE/KDR cell lines was not altered by VEGF165. In contrast, TER of PAE/KDR/Npn-1 cells decreased in dose-dependent fashion following VEGF165 (10 to 200 ng/mL). Activation of VEGFR2, and 2 downstream signaling intermediates (p38 and ERK1/2 MAPK) involved in VEGF-mediated permeability, also increased in PAE/KDR/Npn-1. Consistent with these data, inhibition of Npn-1, but not VEGFR2, attenuated VEGF165-mediated permeability of human pulmonary artery endothelial cells (HPAE), and VEGF121 (which cannot ligate Npn-1) did not alter TER of HPAE. Npn-1 inhibition also attenuated both VEGF165-mediated pulmonary vascular leak and activation of VEGFR2, p38, and ERK1/2 MAPK, in inducible lung-specific VEGF transgenic mice. These data support a critical role for Npn-1 in regulating endothelial barrier dysfunction in response to VEGF and suggest that activation of distinct receptor complexes may determine specificity of cellular response to VEGF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920019     DOI: 10.1161/01.RES.0000171756.13554.49

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  49 in total

Review 1.  Signal transduction by vascular endothelial growth factor receptors.

Authors:  Sina Koch; Lena Claesson-Welsh
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

2.  Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells.

Authors:  Tom T Chen; Alfonso Luque; Sunyoung Lee; Sean M Anderson; Tatiana Segura; M Luisa Iruela-Arispe
Journal:  J Cell Biol       Date:  2010-02-22       Impact factor: 10.539

Review 3.  Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?

Authors:  A R L Medford; A B Millar
Journal:  Thorax       Date:  2006-07       Impact factor: 9.139

4.  Occludin downregulation in high glucose is regulated by SSTR2 via the VEGF/NRP1/Akt signaling pathway in RF/6A cells.

Authors:  Mengling Li; Shuaiwei Wang; Songjiang Wang; Lei Zhang; Dongdong Wu; Ruisheng Yang; Ailing Ji; Yanzhang Li; Jun Wang
Journal:  Exp Ther Med       Date:  2017-06-22       Impact factor: 2.447

5.  Glycocalyx regulation of vascular endothelial growth factor receptor 2 activity.

Authors:  Michelle E LeBlanc; Kahira L Saez-Torres; Issahy Cano; Zhengping Hu; Magali Saint-Geniez; Yin-Shan Ng; Patricia A D'Amore
Journal:  FASEB J       Date:  2019-05-29       Impact factor: 5.191

6.  Increased endothelial progenitor cells and vasculogenic factors in higher-staged arteriovenous malformations.

Authors:  Lingge Lu; Joyce Bischoff; John B Mulliken; Diane R Bielenberg; Steven J Fishman; Arin K Greene
Journal:  Plast Reconstr Surg       Date:  2011-10       Impact factor: 4.730

Review 7.  Regulation of VEGF signaling by membrane traffic.

Authors:  Arie Horowitz; Himabindu Reddy Seerapu
Journal:  Cell Signal       Date:  2012-05-19       Impact factor: 4.315

8.  Angiopoietin-like 4 binds neuropilins and cooperates with VEGF to induce diabetic macular edema.

Authors:  Akrit Sodhi; Tao Ma; Deepak Menon; Monika Deshpande; Kathleen Jee; Aumreetam Dinabandhu; Jordan Vancel; Daoyuan Lu; Silvia Montaner
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

9.  De novo design of a tumor-penetrating peptide.

Authors:  Luca Alberici; Lise Roth; Kazuki N Sugahara; Lilach Agemy; Venkata R Kotamraju; Tambet Teesalu; Claudio Bordignon; Catia Traversari; Gian-Paolo Rizzardi; Erkki Ruoslahti
Journal:  Cancer Res       Date:  2012-11-14       Impact factor: 12.701

10.  Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1.

Authors:  Claudia Prahst; Mélanie Héroult; Anthony A Lanahan; Noa Uziel; Ofra Kessler; Niva Shraga-Heled; Michael Simons; Gera Neufeld; Hellmut G Augustin
Journal:  J Biol Chem       Date:  2008-07-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.